• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status

    inHEART's 3D Cardiac Modeling Tool Earns FDA Nod

    FDA OKs RapidAI's Pulmonary Embolism Triage, Notification Tool

    Kilo Health Invests 500,000 Euros in Pulsetto

    China to Strengthen Robotic Surgical Market With Second 5-Year Plan
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Cybersecurity Challenges Leave Medical Device Makers Insecure

    OEMs Are Demanding Designs that Challenge Suppliers

    Diabetes Technology Manufacturers Seemingly on a Sugar Rush

    Post-Pandemic Partnerships: A Full-Service Outsourcing Discussion

    Discovering the Value of Surface Treatments and Coatings for Medtech
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Injecting Neurostimulators into Blood Vessels (We Swear, It’s Not Sci-Fi)

    Understanding the Costs of Care in the OR

    Sick of Being Sick: Pandemic Fatigue Flares at AAOS

    Managing Critical Healthcare Supply Chains in Turbulent Times

    To Drive Value, Human Capital Leaders Turn to Outsourced Solutions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Xact Wire EDM Corp.

    BMP Medical

    Cirtec Medical

    Concise Engineering

    Arthur G. Russell Co. Inc., The
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    3D Printing in Dental Prosthodontics, Orthodontics, and Surgery

    What New Tech Can Improve Your Medical Manufacturing Plant?

    Why Medical Device Firms Must Navigate the Muddy Waters of ESG Requirements

    Medical Device Servicing vs. Remanufacturing

    Digital Marketplaces for Medical Equipment Come of Age
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Xact Wire EDM Corp.

    BMP Medical

    Cirtec Medical

    Concise Engineering

    Arthur G. Russell Co. Inc., The
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Tethered Polymeric Nanoparticles Weaken Tumors

    New strategy could improve performance of some immune-based drugs.

    Tethered Polymeric Nanoparticles Weaken Tumors
    Related CONTENT
    • Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing
    • Assessing Nanoparticles for Biocompatibility
    • Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings
    • Application Detects Cancer Cells in Abdominal Cavity in Real Time
    • New AI 'Smart Pill' Images Gut to Spot Cancer
    Anne Trafton, MIT News Office03.20.17
    MIT researchers have devised a way to make tumor cells more susceptible to certain types of cancer treatment by coating the cells with nanoparticles before delivering drugs.
     
    By tethering hundreds of tiny particles to the surfaces of tumor cells in the presence of a mechanical force, the researchers made the cells much more vulnerable to attack by a drug that triggers cancer cells to commit suicide. It appears that the tethered nanoparticles increase the forces exerted on the cells by flowing blood, which makes the cells more likely to die.
     
    “When you attach many particles to the membranes of these cells, and then expose them to forces that mimic those in the human body, like blood flow, these therapeutics become more effective. It’s a way of amplifying the forces on the cells using polymeric materials,” said Michael Mitchell, a postdoc at MIT’s Koch Institute for Integrative Cancer Research and the lead author of the study.
     
    In tests in mice, the researchers found that the tethered nanoparticles made the cell-suicide-inducing drug 50 percent more effective, and this combination eliminated up to 90 percent of tumor cells in the mice.
     
    Robert Langer, the David H. Koch Institute Professor at MIT, is the senior author of the paper, which appears in the March 20 issue of Nature Communications.
     
    Enhancing Cell Death
    In addition to studying tumors’ abnormal genetic and biochemical traits, scientists and engineers in recent years have examined how tumors’ physical characteristics contribute to disease progression. Solid tumors exploit physical forces, such as their increased stiffness and altered blood flow, to enhance their survival and growth. Forces exerted by flowing blood and fluid in soft tissues also affect the behavior of cancer and a variety of host cells.
     
    In the new study, the MIT team set out to determine whether physical forces such as those exerted by blood flow might influence how tumors respond to drug treatment. They focused on an experimental drug known as TRAIL, which is a protein expressed on different cells of the immune system. TRAIL is a member of a family of tumor necrosis factors that bind to death receptors on cell membranes, sending them a signal that stimulates apoptosis, or programmed cell death.
     
    Initial experiments revealed that tumor cells became more susceptible to this drug after being exposed to shear forces from physiological fluids. “Under these flow conditions, more tumor cells began to die in the presence of the therapeutic,” Mitchell said.
     
    That led the researchers to hypothesize that they could make cells even more susceptible to the treatment by increasing the forces acting on them. One way to do that is to attach tiny particles to the cell surfaces. Acting like balls on a string, the tethered particles batter and tug at the tumor cell surface as blood flows by, making the cells more susceptible to the cell death signal from the drug.
     
    The particles, which can be injected into the bloodstream, are made of biodegradable polymers known as PLGA. These particles are coated with another polymer, PEG, that is tagged with a ligand or antibody specific to proteins found on tumor cell surfaces, which allows them to be tethered onto the surface.
     
    In tests in mice, the researchers found that attaching particles to tumor cells and then treating them with TRAIL killed metastatic tumor cells in the bloodstream and also reduced the progression of solid tumors in mice. The researchers tested particles ranging from 100 nanometers to 1 micrometer and found that the largest ones were more effective. Also, as greater numbers of particles were tethered to the surface, more cells died.
     
    The effect of the treatment appears to be specific to tumor cells and does not induce apoptosis in healthy cells, the researchers said.
     
    Michael King, a professor of biomedical engineering at Cornell University who was not involved in the research, described the approach as very creative.
     
    “I’ve never seen another study where anyone tried to use particles attached to the cell surfaces to mechanically amplify the cells’ drug sensitivity,” said King, adding that this approach may also be applicable to other drugs.
     
    Forced Interactions
    The researchers believe that the particles may enhance TRAIL’s effects by compressing the shroud of molecules that usually surrounds tumor cells, making it easier for the drug to interact with receptors on the cell surface that turn on the cell death pathway.
     
    “When you expose cells to forces and then these particles are coming down on the cell, they could be flattening all these molecules on the surface. Then the receptor can come in better contact with TRAIL to induce tumor cell death,” Mitchell said.
     
    The MIT team is now exploring the possibility of using this approach in combination with other drugs that stimulate an immune response, such as drugs that induce a “cytokine storm”—a large release of signaling chemicals that attracts many immune cells to the site to destroy the tumor.
     
    “We’re very interested in combined approaches where you can hit tumor cells with many immune-based therapies and then exploit physical forces that these cells are exposed to, as a new way to kill them,” Mitchell said.
    Related Searches
    • mechanical
    • biodegradable
    • paper
    • cancer
    Related Knowledge Center
    • Materials
    Suggested For You
    Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing
    Assessing Nanoparticles for Biocompatibility Assessing Nanoparticles for Biocompatibility
    Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings
    Application Detects Cancer Cells in Abdominal Cavity in Real Time Application Detects Cancer Cells in Abdominal Cavity in Real Time
    New AI New AI 'Smart Pill' Images Gut to Spot Cancer
    Study: Whole Breast Ultrasound Tomography Improves Breast Cancer Risk Assessment Study: Whole Breast Ultrasound Tomography Improves Breast Cancer Risk Assessment
    Hologic Granted EUA for Second COVID-19 Molecular Test Hologic Granted EUA for Second COVID-19 Molecular Test
    World World's First Saliva Test Spots Hidden Throat Cancer
    Blood Test May Help Doctors Catch Pancreatic Cancer Early Blood Test May Help Doctors Catch Pancreatic Cancer Early
    FDA Grants Lucid Diagnostics Breakthrough Device Designation for Esophageal DNA Test FDA Grants Lucid Diagnostics Breakthrough Device Designation for Esophageal DNA Test
    A Noninvasive Method for Deep Brain Stimulation A Noninvasive Method for Deep Brain Stimulation
    Wearable System Helps Visually Impaired Users Navigate Wearable System Helps Visually Impaired Users Navigate
    Making Brain Implants Smaller Could Prolong Their Lifespan Making Brain Implants Smaller Could Prolong Their Lifespan
    Engineering a Kidney-on-a-Chip Engineering a Kidney-on-a-Chip
    Artificial Womb Could Decrease Premature Babies Artificial Womb Could Decrease Premature Babies' Mortality and Disability

    Related Content

    • Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing

      Advanced NanoTherapies Raises $5.3 Million in Seed-Round Financing

      Company accelerates development of its nanoparticle-based drug delivery technology platform to treat peripheral artery disease and other applications.
      Business Wire 11.23.20

    • Testing
      Assessing Nanoparticles for Biocompatibility

      Assessing Nanoparticles for Biocompatibility

      It is important to have an appropriate testing protocol in place for this relatively new medical technology.
      Helin Räägel, Ph.D., Biocompatibility Expert, Nelson Laboratories 09.01.20

    • Chronic Disease | Diagnostics
      Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings

      Diagnostic May Bring Faster, Cheaper Cancer Testing to Remote Settings

      The CytoPAN is used to study breast cells gathered with fine-needle aspiration, a less invasive alternative to standard biopsies.
      American Association for the Advancement of Science 08.07.20


    • Chronic Disease | Diagnostics
      Application Detects Cancer Cells in Abdominal Cavity in Real Time

      Application Detects Cancer Cells in Abdominal Cavity in Real Time

      New approach from Tel Aviv University combines medicine, engineering, and computer science.
      American Friends of Tel Aviv University 07.23.20

    • Diagnostics
      New AI

      New AI 'Smart Pill' Images Gut to Spot Cancer

      Now in prototype development, SmartCap is a new generation diagnostic tool.
      University of Saskatchewan 07.09.20


      Breaking News
      • Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
      • inHEART's 3D Cardiac Modeling Tool Earns FDA Nod
      • FDA OKs RapidAI's Pulmonary Embolism Triage, Notification Tool
      • Kilo Health Invests 500,000 Euros in Pulsetto
      • China to Strengthen Robotic Surgical Market With Second 5-Year Plan
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Cybersecurity Challenges Leave Medical Device Makers Insecure
      • Contract Design for Medtech
      • Diabetes Medical Device Technology Update
      • Medtech Full-Service Outsourcing Q&A 2022

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      PPG Sets Goals to Reduce Greenhouse Gas Emissions, Unveils 2021 ESG Report
      Birla Carbon to Present Sustainable Carbon-based Solutions at PaintIndia 2022
      BTC Europe, NXTLEVVEL Biochem to Distribute Biobased & Biodegradable Solvents in Europe
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Anumana's ECG Pulmonary Hypertension AI Algorithm Gains Breakthrough Status
      inHEART's 3D Cardiac Modeling Tool Earns FDA Nod
      FDA OKs RapidAI's Pulmonary Embolism Triage, Notification Tool
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Corealis CDMO Completes Deal with ArchiMed
      Piramal Pharma Solutions Upgrades Oral Solid Dose Capabilities
      Steriline Robotic Applications to Improve Quality in Drug Primary Packaging
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Glossier Announces New CEO
      Men’s Skincare Market to Hit $13 Billion by End of 2022
      Estée Lauder Promotes Gibu Thomas to EVP, ELC Online
      Happi

      Latest Breaking News From Happi

      Incorrect INCI Prompts Recall of Higher Education Vegan Lip Balm
      Hipdot Launches Girl Scout Cookie-Themed Makeup Collection
      Consumer Dermatology Company Dermala Introduces Second Microbiome-Powdered Line of Products for Eczema-Prone Skin
      Ink World

      Latest Breaking News From Ink World

      HP Indigo Reaches 2,000th Active Install
      Siegwerk Introduces New NC-Based Flexible Packaging Ink
      Sun Chemical Expands SunColorBox with SunConnect
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      AWA to host 22nd Global Release Liner Industry Conference & Exhibition
      Domino assists Grace Label with supply chain disruptions
      Rotocon wins AI Business Excellence Award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Thinx Names Meghan Davis as CEO
      Kimberly-Clark Reportedly Examining Sale of Latin American Tissue
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Extremity Medical Rolls Out OMNI Stable Ankle Fracture System
      James W. Stone Named AANA President
      Tom Hedman Named Senior Principal Scientist at Spinal Simplicity
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Canatu Receives IATF 16949:2016 Certification
      Applied Materials Announces 2Q 2022 Results
      ams OSRAM Supervisory Board to Elect Dr. Margarete Haase as Chairwoman

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login